Point72 (DIFC)’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.3K Sell
4,441
-11,087
-71% -$25.6K ﹤0.01% 758
2025
Q1
$21.6K Buy
+15,528
New +$21.6K ﹤0.01% 670